Action

c-MET

Alt Name

Approval Jurisdiction

2021 China

Approved for clinical use

Adenocarcinoma, NSCLC

Brutto

CAS

1313725-88-0

Commercial Vendor

AZ-HUTCHMED

Compound Image

Savolitinib.png

Compound name

Savolitinib

InChI

InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1

InChI Key

XYDNMOZJKOGZLS-NSHDSACASA-N

MW

345.40

PubChem CID

68289010

Reference

Reference 2

SMILES

CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C

Approved Drug List

1